79 related articles for article (PubMed ID: 19738457)
1. Tenascin-X is a novel diagnostic marker of malignant mesothelioma.
Yuan Y; Nymoen DA; Stavnes HT; Rosnes AK; Bjørang O; Wu C; Nesland JM; Davidson B
Am J Surg Pathol; 2009 Nov; 33(11):1673-82. PubMed ID: 19738457
[TBL] [Abstract][Full Text] [Related]
2. Uroplakin-IIIb as a novel immunohistochemical marker for mesothelioma.
van Pel DM; Cheung S; Ionescu DN; Churg A
Hum Pathol; 2023 Nov; 141():64-68. PubMed ID: 37776956
[TBL] [Abstract][Full Text] [Related]
3. Claudin-10 is a new candidate prognostic marker in metastatic high-grade serous carcinoma.
Davidson B; Doutel D; Holth A; Nymoen DA
Virchows Arch; 2023 Jun; 482(6):975-982. PubMed ID: 37067588
[TBL] [Abstract][Full Text] [Related]
4. Claudin-4 immunocytochemistry is specific and sensitive for the diagnosis of malignant carcinomatous effusions: Results from a pilot study.
Hruaii V; Thirunavukkarasu B; Prabha V; Mathur S; Iyer VK; Nambirajan A; Jain D
Diagn Cytopathol; 2024 Jan; 52(1):30-41. PubMed ID: 37837242
[TBL] [Abstract][Full Text] [Related]
5. Occludin is overexpressed in tubo-ovarian high-grade serous carcinoma compared to mesothelioma and is a marker of tumor progression and chemoresistance.
Dos Santos MV; Holth A; Bischof K; Davidson B
Clin Exp Metastasis; 2024 Feb; 41(1):69-76. PubMed ID: 38141113
[TBL] [Abstract][Full Text] [Related]
6. Multiple peimary cancers in patient with malignant pleural mesothelioma and ovarian serous carcinoma: A case report.
Tian D; Wang H; Zhu B; Liu H
Asian J Surg; 2024 Mar; ():. PubMed ID: 38480095
[No Abstract] [Full Text] [Related]
7. Triple-layer dissection of the lung adenocarcinoma transcriptome: regulation at the gene, transcript, and exon levels.
Hsu MK; Wu IC; Cheng CC; Su JL; Hsieh CH; Lin YS; Chen FC
Oncotarget; 2015 Oct; 6(30):28755-73. PubMed ID: 26356813
[TBL] [Abstract][Full Text] [Related]
8. Recurrent gastrointestinal perforation in a patient with Ehlers-Danlos syndrome due to tenascin-X deficiency.
Sakiyama T; Kubo A; Sasaki T; Yamada T; Yabe N; Matsumoto K; Futei Y
J Dermatol; 2015 May; 42(5):511-4. PubMed ID: 25772043
[TBL] [Abstract][Full Text] [Related]
9. Tenascin-X gene defects and cardiovascular disease.
Morissette R; McDonnell NB; Merke DP
Med Hypotheses; 2014 Dec; 83(6):844. PubMed ID: 24709065
[No Abstract] [Full Text] [Related]
10. The role of TNXB single-nucleotide polymorphisms in recurrent shoulder dislocation.
Geiger EV; Henrich D; Wutzler S; Schneidmüller D; Jakob H; Frank JM; Marzi I
J Orthop Res; 2013 Feb; 31(2):295-9. PubMed ID: 22991340
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic effects of Ehlers-Danlos syndrome-associated mutation on the FnIII domain of tenascin-X.
Zhuang S; Linhananta A; Li H
Protein Sci; 2010 Oct; 19(11):2231-9. PubMed ID: 20853426
[TBL] [Abstract][Full Text] [Related]
12. KYNU as a Biomarker of Tumor-Associated Macrophages and Correlates with Immunosuppressive Microenvironment and Poor Prognosis in Gastric Cancer.
Shen K; Chen B; Yang L; Gao W
Int J Genomics; 2023; 2023():4662480. PubMed ID: 37954130
[TBL] [Abstract][Full Text] [Related]
13. Tenascin-X as a causal gene for classical-like Ehlers-Danlos syndrome.
Okuda-Ashitaka E; Matsumoto KI
Front Genet; 2023; 14():1107787. PubMed ID: 37007968
[TBL] [Abstract][Full Text] [Related]
14. Integrated proteome and phosphoproteome analysis of gastric adenocarcinoma reveals molecular signatures capable of stratifying patient outcome.
Lu X; Fu Y; Gu L; Zhang Y; Liao AY; Wang T; Jia B; Zhou D; Liao L
Mol Oncol; 2023 Feb; 17(2):261-283. PubMed ID: 36520032
[TBL] [Abstract][Full Text] [Related]
15. Revisiting the Tenascins: Exploitable as Cancer Targets?
Tucker RP; Degen M
Front Oncol; 2022; 12():908247. PubMed ID: 35785162
[TBL] [Abstract][Full Text] [Related]
16. Epigenome-Wide DNA Methylation Profiling in Colorectal Cancer and Normal Adjacent Colon Using Infinium Human Methylation 450K.
Baharudin R; Ishak M; Muhamad Yusof A; Saidin S; Syafruddin SE; Wan Mohamad Nazarie WF; Lee LH; Ab Mutalib NS
Diagnostics (Basel); 2022 Jan; 12(1):. PubMed ID: 35054365
[TBL] [Abstract][Full Text] [Related]
17. Identification of Overexpressed Genes in Malignant Pleural Mesothelioma.
Morani F; Bisceglia L; Rosini G; Mutti L; Melaiu O; Landi S; Gemignani F
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800494
[TBL] [Abstract][Full Text] [Related]
18. Loss of Tenascin-X expression during tumor progression: A new pan-cancer marker.
Liot S; Aubert A; Hervieu V; Kholti NE; Schalkwijk J; Verrier B; Valcourt U; Lambert E
Matrix Biol Plus; 2020 May; 6-7():100021. PubMed ID: 33543019
[TBL] [Abstract][Full Text] [Related]
19. Genome wide methylation profiling of selected matched soft tissue sarcomas identifies methylation changes in metastatic and recurrent disease.
Vargas AC; Gray LA; White CL; Maclean FM; Grimison P; Ardakani NM; Bonar F; Algar EM; Cheah AL; Russell P; Mahar A; Gill AJ
Sci Rep; 2021 Jan; 11(1):667. PubMed ID: 33436720
[TBL] [Abstract][Full Text] [Related]
20. The Roles of Tenascins in Cardiovascular, Inflammatory, and Heritable Connective Tissue Diseases.
Matsumoto KI; Aoki H
Front Immunol; 2020; 11():609752. PubMed ID: 33335533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
